carmofur and Uterine Cervical Neoplasms

carmofur has been researched along with Uterine Cervical Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsui, Y; Okudaira, Y; Sawada, M1
Ikeda, M; Kubo, H; Nakajima, H; Noda, K; Okamura, S; Sugawa, T; Sugimoto, O; Teshima, K; Yamabe, T; Yamagata, S1

Trials

1 trial(s) available for carmofur and Uterine Cervical Neoplasms

ArticleYear
[Long-term administration of carmofur as a post-operative adjuvant chemotherapy for cervical adenocarcinoma. Cervical Adenocarcinoma Cooperative Research Association].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:12

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Registries; Survival Rate; Uterine Cervical Neoplasms

1994

Other Studies

1 other study(ies) available for carmofur and Uterine Cervical Neoplasms

ArticleYear
Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue.
    Nihon Sanka Fujinka Gakkai zasshi, 1983, Volume: 35, Issue:12

    Topics: Antineoplastic Agents; Female; Fluorouracil; Humans; Ovarian Neoplasms; Uterine Cervical Neoplasms

1983